One of the most promising new life-saving advancements in cancer care is Immunotherapy, which is a way to use your body’s own immune system to eliminate your cancer. Sound too good to be true? Read on to find out how it works!
See how Immunotherapy has helped cancer patients like you. Read about how we helped colon cancer survivor Damian and melanoma survivor Joan, using the Four Pillars of Precision Oncology (including Immunotherapy).
The American Society of Clinical Oncology voted Immunotherapy as its top overall clinical advancement for both 2016 and 2017. So what, exactly, is it?
Immunotherapy uses the body's own immune system to treat cancer. The body's immune system uses a "series of checkpoints" to determine if cells are normal or a threat. Some forms of cancer bond with proteins similar to normal cells, which acts like a cloaking shield for the immune system. Immunotherapy medication inhibits the cancer cells from bonding with those proteins, effectively deactivating the cloaking shield, and allowing the body’s own immune system to kill the cancer cells. The American Cancer Society has declared that Immunotherapies "have already become an important part of the treatment for many cancers."Scientific Research and Advocacy Team
As a type of targeted treatment, Immunotherapy allows the body’s own immune system to find the cells with mutated gene(s), which leads to higher survival rates with fewer and less severe side effects.Scientific Research and Advocacy Team
However, not all cancers use this "cloaking" mechanism for hiding from the immune system, Scientific Research and Advocacy Teamach of our clients a special blood test to find out right away if immunotherapy will work for them. This means patients only get the treatment that’s going to be most helpful to them and time is not wasted on treatments that are not right for the patient.
Many Cancer Treatment Options and Management patients have found success with Immunotherapy. For example, Joan reached out to CTOAM when she was diagnosed with stage IV melanoma. Her public oncologist told her there was nothing more they could do for her. But she and her husband had been researching on their own and knew better. So they called our cancer research and patient advocacy experts to help them access the right targeted treatments for her unique genetic mutations.
Cancer Treatment Options and Management helped Joan to become one of the first cancer patients in Canada to be treated with immunotherapy and Joan has now been completely cancer-free for several years now! See how immunotherapy and other targeted treatments have helped our other patients live longer, with a higher quality of life, and even become cancer-free in our Patient Success Stories.
Find out if Immunotherapy can work for you – talk to CTOAM’s cancer research and patient advocacy experts today!
CTOAM is, and will always be, years ahead of standard care. Why? Because our cancer research and patient advocacy experts spend every day researching the latest advancements in cancer care. Our use of immunotherapy is a good example of this: we’ve been using immunotherapy with cancer patients for four years now – long before standard care started to use it.
Joan first received immunotherapy through Cancer Treatment Options and Management in 2014, back when it was virtually unheard of within the public medical system. At the time, Cancer Treatment Options and Management ’s medical team was well aware of the large amount of data supporting immunotherapy for cancer treatment; we knew it was worth trying and that the results would likely be successful for patients like Joan. And we were right.
Take the first step toward feeling better and having more time with your loved ones: Make sure you have access to the most powerful diagnostic tools and treatments that medical science has to offer – with expert guidance from our medical team every step of the way.
Register for a Precision Second Opinion with our medical team today.
Get the latest advancements in cancer care delivered straight to your inbox each month!